ATLAS / Macro Radar / Reporting / URGN

UroGen Pharma Ltd. (URGN) reporting calendar

UroGen Pharma Ltd. files periodic reports with the SEC as URGN on Nasdaq. Atlas tracks 31 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 25 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
6 May 2026
Reports on record
31

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 40 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open URGN market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 20266 May 202636 days0001437749-26-015019
10-K31 Dec 20252 Mar 202661 days0001437749-26-006234
10-Q30 Sep 20256 Nov 202537 days0001437749-25-033468
10-Q30 Jun 20257 Aug 202538 days0001437749-25-025243
10-Q31 Mar 202512 May 202542 days0001437749-25-015956
10-K31 Dec 202410 Mar 202569 days0001437749-25-006842
10-Q30 Sep 20246 Nov 202437 days0001437749-24-033454
10-Q30 Jun 202413 Aug 202444 days0001437749-24-026161
10-Q31 Mar 202413 May 202443 days0001437749-24-016116
10-K31 Dec 202314 Mar 202474 days0001437749-24-007753
10-Q30 Sep 202314 Nov 202345 days0001437749-23-031766
10-Q30 Jun 202310 Aug 202341 days0001437749-23-022879
10-Q31 Mar 202311 May 202341 days0001437749-23-013767
10-K31 Dec 202224 Mar 202383 days0001437749-23-007710
10-Q30 Sep 202210 Nov 202241 days0001437749-22-026727
10-Q30 Jun 202211 Aug 202242 days0001437749-22-020131
10-Q31 Mar 202210 May 202240 days0001437749-22-011618
10-K31 Dec 202121 Mar 202280 days0001437749-22-006778
10-Q30 Sep 202115 Nov 202146 days0001437749-21-026620
10-Q30 Jun 20214 Aug 202135 days0001564590-21-040510
10-Q31 Mar 202113 May 202143 days0001564590-21-027210
10-K31 Dec 202018 Mar 202177 days0001564590-21-014016
10-Q30 Sep 20209 Nov 202040 days0001564590-20-052197
10-Q30 Jun 202010 Aug 202041 days0001564590-20-038611
10-Q31 Mar 20207 May 202037 days0001564590-20-022352
10-K31 Dec 20192 Mar 202062 days0001564590-20-007970
10-Q30 Sep 201912 Nov 201943 days0001564590-19-042553
10-Q30 Jun 20199 Aug 201940 days0001564590-19-031042
10-Q31 Mar 20199 May 201939 days0001564590-19-017568
10-K31 Dec 201828 Feb 201959 days0001564590-19-005323
20-F31 Dec 201715 Mar 201874 days0001564590-18-005876

Source: SEC EDGAR company submissions for CIK 0001668243. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.